Paving the Way for Biomedical Innovation

The Frederick National Laboratory meets the nation’s most urgent biomedical research needs and serves as a national and global resource for the scientific community. 

Biotech Connector illuminates structural biology research

Structural biology has been in existence since 1912, when German physicist Max Von Laue first directed X-rays at crystallized...

Symposium: Technology Showcase team blends new and old approaches for 2024 event

After eight years, the annual Technology Showcase isn’t showing any signs of slowing. In fact, according to members of the...

Study offers guidance for targeting HIV’s viral reservoir

After decades of progress, people with HIV now have access to drugs that keep the virus undetectable and thus under control...

Demographically diverse images are sought for national cancer resource

Scientists from the National Cancer Institute and the Frederick National Laboratory for Cancer Research are urging medical...

Conference: Black in Cancer Conference draws Black cancer research professionals to first U.S. event

The inaugural U.S. Black in Cancer Conference brought more than 300 oncologists, scientists, students, trainees, advocates...

'Empanada' is a leap forward in rapid 3-D image processing and annotation

It sounds like a pastry but it’s really part of a new wave in scientific imaging. Empanada is the name of an artificial...

Newly identified antibodies block many influenza strains in laboratory tests

Seeking a universal flu vaccine, scientists have identified two antibodies that block a wide range of influenza viruses by...
What is this?

The Nanotechnology Characterization Laboratory characterizes nanomedicine formulations, as seen in this assay, for physiochemical traits and immunology, pharmacology and toxicology properties.

Information
Initiative

RAS Initiative

The RAS Initiative mobilizes the cancer research community to develop ways to treat cancers driven by the mutant RAS gene in an open model of collaboration among government, academic, and industry researchers.
220,000
People per year in the U.S. are diagnosed with cancers caused by KRAS mutations.
What is this? Surface representation of the structure of an oncogenic mutant of KRAS in complex with RAS-binding domains of RAF1 Kinase. The GMPPNP bound to oncogenic KRAS mutant is shown in ball-and-stick representation.
Information
Initiative

Scientific Standards Hub

Our scientists establish standards and reference reagents for diverse scientific  disciplines and  encourage the adoption of benchmarks  among researchers. 
8
disciplines with tools to help bridge gaps in scientific reproducibility.

Our Passion is Infectious

Shape Your Career

Work with the best of the best biomedical researchers and investigators. Be a part of groundbreaking solutions that benefit public health throughout the world. And, enjoy some of the best benefits in the region. We are looking for smart, passionate problem solvers for benchwork, data science, manufacturing, and more.